z-logo
Premium
Hypercalciuria and nephrolithiasis: Expanding the renal phenotype of Donnai‐Barrow syndrome
Author(s) -
Anglani F.,
Terrin L.,
Brugnara M.,
Battista M.,
Cantaluppi V.,
Ceol M.,
Bertoldi L.,
Valle G.,
Joy M.P.,
Pober B.R.,
Longoni M.
Publication year - 2018
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.13242
Subject(s) - hypercalciuria , nephrocalcinosis , phenotype , exome sequencing , medicine , proteinuria , clinical phenotype , renal tubular acidosis , kidney stones , kidney disease , endocrinology , genetics , pathology , kidney , biology , gene , urinary system , acidosis
Whole exome sequencing detected novel likely pathogenic variants in LRP2 gene in 2 patients presenting with hearing and vision loss, and the Dent disease (DD) classical renal phenotype, that is, low molecular weight proteinuria (LMWP), hypercalciuria and nephrocalcinosis/nephrolithiasis. We propose that a subset of patients presenting as DD may represent unrecognized cases or mild forms of Donnai‐Barrow/facio‐oculo‐acustico‐renal (DB/FOAR) syndrome or be on the phenotypic continuum between the 2 conditions.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom